Types of Peptides
Feeling low on energy or struggling with focus or recovery? At Sky Health Wellness Clinic in Las Vegas, our licensed medical team offers physician-supervised peptide therapies that include both FDA-approved medications and compounded formulations sourced from FDA-registered 503B pharmacies.
FDA-approved peptide medications, such as Semaglutide and Tirzepatide, are prescribed for their approved indications and administered under professional care. Compounded peptide formulations are not FDA-approved drugs and are provided only when medically appropriate and prescribed by a licensed clinician. Each plan is developed to support your health goals under careful supervision and transparency.
Peptides are used to target individual needs.
Medical Disclaimer
This page, including all descriptions of peptide therapies, is provided for informational purposes only and does not constitute medical advice. Peptide treatments should only be administered under the supervision of a qualified, licensed healthcare provider. Individual responses to therapy may vary, and outcomes cannot be guaranteed. To learn more, view our Legal Notice & Patient Responsibility section or visit our medical disclaimer page.
Precise Targeting of Chronic Issues
Help Improve Your Quality of Life
What is Peptide Therapy?
Peptide therapy uses short chains of amino acids known as peptides to mimic and support natural hormones in your body. These targeted treatments regulate key functions such as appetite control, metabolism, energy levels and hormone balance.
At Sky Health Wellness Clinic in Las Vegas, our medical providers offer physician-supervised peptide therapy as part of individualized wellness programs. Peptides are short chains of amino acids that occur naturally in the body and play important roles in biological signaling.
Our clinic offers both FDA-approved peptide medications, such as Semaglutide and Tirzepatide, and compounded peptide formulations from FDA-registered 503B pharmacies when medically appropriate. All treatments are prescribed and monitored by licensed providers to ensure safety, transparency, and individualized care.
Peptide-based therapies may be incorporated into personalized care plans to help support wellness, metabolism, and overall health under medical supervision. Compounded peptide formulations are not FDA-approved drugs and are provided only when clinically indicated.
Personalized Peptide Innovations
Revolutionized Wellness
Benefits of Peptide Therapy
At Sky Health Wellness Clinic in Las Vegas, our medical providers offer physician-supervised peptide treatments designed to support specific health goals. We provide both FDA-approved peptide medications and compounded formulations sourced from FDA-registered 503B pharmacies when clinically appropriate.
While individual results vary, peptide-based therapies may be used under medical supervision to help support areas such as:
-
Metabolic Health: Managing weight and supporting healthy glucose metabolism through FDA-approved options like Semaglutide and Tirzepatide.
-
Recovery and Repair: Physician-directed use of select compounded peptides, when prescribed, may assist in general wellness or recovery goals.
-
Well-Being and Energy: Comprehensive programs developed by licensed clinicians to help patients feel their best under ongoing monitoring.
All peptide treatments at Sky Health are developed in accordance with medical oversight, transparent sourcing, and patient-specific evaluation. Compounded peptide formulations are not FDA-approved drugs and are offered only when medically necessary and prescribed by a licensed provider.
Before starting any peptide therapy, consult with our clinicians or your primary care provider to determine whether a peptide-based approach is appropriate for your care plan.
Discover the impact of this tailored approach by booking your customized peptide therapy session now.
AOD-9604 Peptide
AOD-9604 is a synthetic peptide fragment derived from a portion of human growth hormone (HGH). It was originally developed and studied for its potential effects on metabolic processes and body composition. Research on AOD-9604 has focused on how specific peptide fragments may interact with cellular pathways related to energy regulation and physiological signaling.
AOD-9604 is not an FDA-approved drug and has not been approved for the treatment of obesity, metabolic disorders, fat reduction, or any disease-related condition. Its use in clinical settings remains investigational, and it is available only through licensed healthcare providers who determine when a research-based peptide may be considered appropriate for patient-specific wellness plans.
What to Expect from AOD-9604 Therapy:
-
Medical Oversight: All treatment plans are developed and monitored by licensed medical providers.
-
Individualized Dosing: Protocols are customized according to health goals, lab results, and patient tolerance.
-
Comprehensive Support: Each program may include recommendations for nutrition, physical activity, and lifestyle factors to promote safe, balanced results.
-
Transparency and Safety: AOD-9604 is not FDA-approved for fat loss or metabolic disorders and should only be used under clinical supervision.
Who May Be Considered for AOD-9604 Therapy:
-
Adults seeking physician-supervised wellness programs focused on general wellness and lifestyle support.
-
Patients under professional care are exploring peptide-based therapies for research-related or adjunctive purposes.
-
Individuals referred by a licensed healthcare provider for personalized metabolic support.
Important Legal and Regulatory Information:
-
Not FDA-Approved: AOD-9604 is not approved for weight loss, metabolic disorders, or any medical condition.
-
Investigational Status: It may only be used in contexts where investigational, off-label care is permitted and medically supervised.
-
Quality Concerns: Compounded or research-labeled versions may vary in purity and manufacturing quality.
-
Military Members: U.S. service members should avoid peptide hormones and non-FDA-approved peptide products, as many appear on the Department of Defense’s prohibited dietary supplement list.
At Sky Health Wellness Clinic, our emphasis is on safe, transparent, and evidence-informed care. AOD-9604 is discussed only when medically appropriate and compounded through FDA-registered pharmacies that follow current good manufacturing practices (cGMP). Our goal is to provide patients with clear information so they can make informed decisions in collaboration with their licensed provider.
ARA-290 Peptide
ARA-290 is a synthetic peptide studied for its interaction with the innate repair receptor (IRR), a receptor involved in cellular signaling pathways related to inflammation and tissue responses. Research on ARA-290 has primarily taken place in laboratory and early clinical environments, exploring how it may influence cellular repair processes and immune modulation.
In the United States, ARA-290 is not FDA-approved for any medical indication. It is not approved for neuropathy, inflammation, chronic pain, injury recovery, or cognitive support. Any consideration of ARA-290 within a clinical setting is strictly investigational and requires careful oversight by a licensed medical provider.
What to Expect from ARA-290 Therapy:
-
Clinical Review: A licensed provider will assess your medical history and wellness goals to determine whether investigational peptide options such as ARA-290 are appropriate for discussion.
-
Supervised Administration: If a provider determines that ARA-290 is suitable within an investigational framework, dosing and scheduling will occur under medical supervision.
-
Ongoing Monitoring: Providers may periodically review patient-reported experiences and tolerance to ensure safe and responsible oversight.
-
Supportive Guidance: Patients may receive general recommendations on lifestyle practices that complement overall wellness goals.
Who May Be Considered for ARA-290 Therapy:
-
Adults participating in clinician-supervised programs that explore investigational peptides.
-
Individuals referred by their healthcare provider for evaluation of non-FDA-approved peptide options.
-
Patients seeking structured medical oversight when discussing emerging peptides or research-based compounds.
-
Adults interested in learning about peptides with ongoing scientific investigation under regulated clinical guidance.
Who May Be Considered for ARA-290 Therapy:
-
Not FDA-Approved: ARA-290 is not approved by the U.S. Food and Drug Administration for any therapeutic use.
-
Investigational Status: It cannot be marketed or sold for treatment of neuropathy, inflammation, chronic pain, or any medical condition.
-
Quality Concerns: Products sold online or labeled as “research chemicals” may lack pharmaceutical-grade purity, sterility, or consistency.
-
Off-Label Use: Any use of ARA-290 must be conducted with informed consent and direct medical supervision due to limited human safety data.
-
Military Members: U.S. service members should avoid peptide hormones and non-FDA-approved peptide products, as many appear on the Department of Defense’s prohibited dietary supplement list.the
At Sky Health Wellness Clinic, ARA-290 is discussed only within the context of medically supervised, evidence-informed care. Our priority is patient safety, regulatory compliance, and clear education regarding investigational peptides. We help patients understand the scientific background, legal status, and limitations of research peptides so they can make informed decisions in collaboration with a licensed provider.
BPC-157 Peptide
BPC-157 is a synthetic peptide derived from a sequence found in a naturally occurring gastric protein. It has been studied primarily in preclinical and laboratory settings for its potential influence on cellular signaling, angiogenesis, and tissue responses. While these studies have generated interest in wellness and research environments, there are no FDA-approved uses for BPC-157, and it has not been evaluated for safety or effectiveness in humans.
Because human clinical trials are extremely limited, the therapeutic value, risks, interactions, and long-term effects of BPC-157 remain uncertain. Any discussion of this peptide must be framed within investigational and research-based contexts only.
What to Expect from BPC-157 Therapy:
-
Clinical Review: A licensed healthcare provider evaluates your health history and wellness goals to determine whether discussing investigational peptides like BPC-157 is appropriate.
-
Supervised Use Only: If BPC-157 is considered within a monitored wellness plan, any dosing schedule is provided strictly under medical supervision.
-
Monitoring and Evaluation: Providers may review your tolerance, reported experiences, and overall response for safety oversight.
-
Lifestyle Support: Patients may receive general guidance regarding nutrition, mobility, and wellness habits as part of their broader care plan.
Who May Be Considered for BPC-157 Therapy:
-
Adults exploring investigational peptides under the guidance of a licensed provider.
-
Individuals participating in clinician-supervised wellness programs where research peptides are reviewed.
-
Patients referred for evaluation of non-FDA-approved peptides within a structured medical environment.
-
Adults seeking medical oversight when considering emerging peptide compounds.
Important Legal and Regulatory Information:
-
Not FDA-Approved: BPC-157 is not approved for any medical use, including injury recovery, inflammation, gut health, musculoskeletal conditions, or post-surgical support.
-
Research Chemical Status: Products sold online or labeled as “research compounds” vary widely in purity and quality and are not pharmaceutical-grade.
-
Investigational Use Only: Any use of BPC-157 outside of laboratory research settings is considered off-label and requires informed consent and medical supervision.
-
Military Members: U.S. service members should avoid peptide hormones and non-FDA-approved peptide products, as many appear on the Department of Defense’s prohibited dietary supplement list.
If you'd like to learn more, visit our learning center's Ultimate Guide to BPC-157.
At Sky Health Wellness Clinic, our priority is transparent, evidence-informed guidance. BPC-157 is discussed only within investigational contexts and under professional supervision, with a strong emphasis on safety, legality, and patient education. We help individuals understand the scientific background and regulatory status of research peptides so they can make informed choices with their licensed provider.
CJC-1295 Peptide
CJC-1295 is a synthetic analog of growth hormone–releasing hormone (GHRH) that has been explored in research settings for its ability to influence pulsatile growth hormone patterns. Most findings come from early-phase or experimental studies, and its long-term safety and clinical value in humans remain under investigation. CJC-1295 is not approved by the FDA for treating any medical condition, including hormone imbalance, aging-related concerns, body composition, or recovery.
Because evidence in human subjects is limited, CJC-1295 is considered an investigational peptide that should only be discussed within a structured medical environment that emphasizes safety, oversight, and patient education.
What to Expect from CJC-1295 Therapy:
-
Medical Oversight: Licensed medical providers review your health history, labs, and goals to determine whether discussing investigational peptides is appropriate.
-
Individualized Dosing Plans: If included in a supervised wellness plan, dosing schedules are tailored according to patient tolerance and safety considerations.
-
Ongoing Monitoring: Providers may track your response, adjust protocols if needed, and review general wellness markers as part of responsible oversight.
-
Holistic Support: Recommendations may include lifestyle, nutrition, and sleep guidance to support your broader wellness objectives.
Who May Be Considered for CJC-1295 Therapy:
-
Adults participating in medically supervised wellness programs exploring investigational peptides.
-
Individuals interested in understanding emerging hormone-modulating compounds under clinical guidance.
-
Patients referred by a licensed provider for evaluation of non-FDA-approved peptides in a structured care setting.
-
Adults seeking professional support when considering early-stage research compounds.
Important Legal and Regulatory Information:
-
Not FDA-Approved: CJC-1295 is not approved for treating low growth hormone, age-related conditions, metabolic issues, athletic recovery, or any therapeutic purpose.
-
Research Status: CJC-1295 is classified as an investigational compound. Purity, potency, and consistency can vary significantly in non-pharmaceutical sources marketed online.
-
Medical Supervision Required: Any use should occur only under clinician oversight, with informed consent outlining the investigational nature and unknown long-term risks.
-
Military Personnel Warning: U.S. service members should avoid non-FDA-approved peptide hormones. Many peptides appear on the Department of Defense’s prohibited dietary supplement list and may affect readiness screenings.
At Sky Health Wellness Clinic, we emphasize transparency, safety, and evidence-informed guidance when discussing peptide-based wellness options. CJC-1295 is reviewed only within an investigational context and under licensed medical supervision. Our role is to help patients understand the scientific background, legal status, and potential risks of emerging peptides so they can make informed decisions in a medically supported environment.
Dihexa Peptide
Dihexa (also known as N-hexanoic-tyrosine-isoleucine-hexanoamide) is an investigational compound originally developed for neurological research. Early laboratory work has examined its ability to influence synaptic connections and support neuronal signaling, but these findings come primarily from animal studies and in-vitro models, not from human clinical trials. Dihexa has not been evaluated or approved by the FDA for cognitive, neurological, anti-aging, or therapeutic use of any kind.
Because of its limited safety data and lack of regulated manufacturing standards, Dihexa is considered a high-risk experimental compound. Its discussion in a wellness setting focuses on patient education, transparency, and informed decision-making, not on therapeutic claims.
Key Educational Points About Dihexa:
-
Research-Based Background: Dihexa has been studied in preclinical environments for its potential effects on synaptic density and neuronal signaling, but no conclusions can be drawn about benefits or risks in humans due to the absence of controlled human studies.
-
Unverified Cognitive Claims: Many claims circulating online—such as improved memory, sharper thinking, or neuroprotection—are not supported by FDA-recognized evidence.
-
Unknown Risk Profile: Animal studies have raised concerns, including possible carcinogenic mechanisms, although real-world human risk remains unknown due to a lack of clinical research.
-
Variable Product Quality: Because Dihexa is not approved or regulated, purity and potency vary widely among suppliers, increasing the risk of contamination or incorrect dosing.
-
Professional Guidance Required: Any conversation regarding Dihexa should occur only under the supervision of a licensed medical provider who can prioritize safety, disclaim investigational status, and help patients understand the limitations of current data.
Who May Discuss Dihexa in a Clinical Setting:
-
Adults seeking education about emerging or investigational neuroactive compounds.
-
Individuals referred by a clinician for an informational consultation regarding experimental peptides.
-
Patients who want guidance in evaluating the risks, unknowns, and regulatory status of non-approved cognitive enhancement substances.
-
People exploring research compounds and needing clarity on evidence, safety, legality, and responsible oversight.
Important Legal and Regulatory Information:
-
Not FDA-Approved: Dihexa is not approved to treat memory loss, cognitive decline, neurodegenerative disease, learning difficulties, or any medical condition.
-
Not Legal to Market as a Therapy: Dihexa cannot be sold, advertised, or promoted in the U.S. as a therapeutic or cognitive-enhancing product.
-
Investigational Status: There are no clinical trials establishing dose, safety, benefit, or long-term effects in humans; its use carries significant uncertainty.
-
Quality and Contamination Risks: Because it is not manufactured under regulated pharmaceutical standards, Dihexa products may contain impurities or inaccurate concentrations.
-
Military Personnel Warning: U.S. service members should avoid Dihexa and similar non-approved peptide compounds. Many neuroactive and hormone-modulating substances appear on the Department of Defense’s prohibited dietary supplement list and can lead to adverse findings during readiness or medical screenings.
At Sky Health Wellness Clinic, our priority is patient safety, accuracy, and transparency. Discussions around Dihexa focus on helping patients understand the scientific background, the lack of FDA oversight, and the uncertain safety profile associated with investigational peptides. Our providers ensure that any consideration of emerging compounds is grounded in evidence-informed guidance and responsible clinical judgment.
%20Peptide%20Therapy%20Las%20Vegas.webp)
Follistatin-344 Peptide
Follistatin-344 is a synthetic research peptide derived from naturally occurring follistatin, a protein involved in regulating muscle development and cellular growth. Laboratory studies have examined how follistatin interacts with myostatin and other growth-related pathways, but these findings remain experimental and have not been validated in controlled human clinical trials. Follistatin-344 is not approved by the FDA for increasing muscle mass, improving performance, supporting recovery, or treating any medical condition.
Because of its investigational status and lack of long-term safety data, Follistatin-344 is discussed in a clinical setting only for educational purposes and to help patients understand emerging peptide research, regulatory limitations, and potential risks.
Key Educational Points About Follistatin-344:
-
Research Background: Early studies have explored how follistatin proteins interact with myostatin signaling, which plays a role in muscle regulation. These studies do not establish safety, dosage, or effectiveness for human therapeutic use.
-
Unverified Muscle Growth Claims: Claims circulating online about dramatic hypertrophy, fat loss, or performance enhancement are not supported by FDA-recognized clinical data.
-
Unknown Risk Profile: There is limited information on long-term effects, potential hormonal disruption, or interactions with existing health conditions. The risk profile for humans remains largely undetermined.
-
Product Variability: Because Follistatin-344 is not manufactured under pharmaceutical standards, purity and potency can vary, increasing the chance of contamination or incorrect concentrations.
-
Professional Oversight Recommended: Any educational conversation regarding Follistatin-344 should occur with a licensed provider who can explain regulatory limitations, safety considerations, and whether discussion of investigational compounds is appropriate.
Who May Discuss Follistatin-344 in a Clinical Setting:
-
Adults seeking information about experimental peptides referenced in early research.
-
Individuals exploring non-approved compounds who require clarity about risks, unknowns, and regulatory issues.
-
Patients interested in understanding the scientific background of emerging muscle-related peptide research.
-
People wanting professional guidance on the difference between online claims and evidence-supported data.
Important Legal and Regulatory Information:
-
Not FDA-Approved: Follistatin-344 is not approved for muscle growth, fat reduction, anti-aging, performance enhancement, or treatment of any disease.
-
Not Legal to Market as Therapy: It cannot be legally sold or advertised in the U.S. as a medical or performance-enhancing treatment.
-
Investigational Compound: Safety, dosing, long-term effects, and clinical applications have not been established through human trials.
-
Manufacturing Risks: Non-regulated manufacturing increases the risk of impurities or inaccurate potency.
-
Military Advisory: U.S. service members should avoid non-FDA-approved peptides, including Follistatin-344. Many hormone-modulating compounds appear on the Department of Defense’s prohibited ingredients list and may trigger adverse findings in readiness or medical screenings.
At Sky Health Wellness Clinic, discussions about Follistatin-344 focus on transparency, safety, and evidence-informed guidance. Our role is to help individuals understand the state of current research, regulatory restrictions, and the unknown risks associated with investigational peptides. All conversations occur under licensed clinical supervision to ensure that patient decisions are grounded in accurate, responsible information.
GHK-Cu Peptide
GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring copper-binding tripeptide found in human plasma, saliva, and tissues. It has been studied for its roles in skin repair, collagen production, antioxidant activity, and wound remodeling. Research has explored its potential in dermatology, hair restoration, and tissue regeneration, although many applications remain investigational and are not FDA-approved for therapeutic claims.
In clinical and wellness settings, GHK-Cu may be utilized in topical or injectable forms under professional supervision. Treatment decisions should be based on individual evaluation, skin health goals, and tolerance.
Key Considerations for GHK-Cu Use:
Collagen and Skin Support: Studies show GHK-Cu can stimulate fibroblasts, support collagen and elastin synthesis, and contribute to improved firmness and texture.
Wound-Healing Pathways: Research suggests GHK-Cu may promote angiogenesis and anti-inflammatory responses, potentially supporting recovery from injuries and skin procedures.
Hair Follicle Activity: GHK-Cu has been evaluated for its ability to influence follicle signaling and may aid in scalp health and hair density under guided care.
Antioxidant Modulation: The peptide is known for regulating oxidative stress markers and influencing inflammatory cytokines in laboratory models.
Flexible Administration: Depending on clinical goals, GHK-Cu may be used as a topical cream, serum, or, in some cases, via subcutaneous injection when prescribed by a licensed provider.
Who May Be Considered for GHK-Cu-Based Care:
-
Adults seeking clinician-guided support for skin quality, firmness, or non-invasive cosmetic wellness.
-
Individuals recovering from dermatologic procedures require enhanced tissue support.
-
Patients addressing hair health under supervised care.
-
Those exploring inflammation-related skin concerns with a licensed clinician.
Important Legal and Regulatory Information:
Not FDA-Approved for Cosmetic or Therapeutic Use: GHK-Cu is not FDA-approved for anti-aging, wrinkle reduction, hair regrowth, wound healing, or treatment of any disease. Its use for skin or hair support is considered off-label and must be medically supervised.
Not Legal to Market as a Therapy for Unapproved Claims: GHK-Cu cannot be legally sold or advertised in the U.S. as a treatment for anti-aging, cosmetic enhancement, tissue repair, or hair growth. Any promotional claims outside a research-supported context are prohibited.
Investigational Compound: Safety, dosing, long-term effects, and clinical outcomes for cosmetic or regenerative use have not been established through FDA-regulated clinical trials. Providers must evaluate appropriateness case-by-case.
Manufacturing and Quality Risks: Compounded or cosmetic-grade GHK-Cu products are not FDA-regulated. Purity, potency, and sterility may vary. Only pharmacies following current good manufacturing practices (cGMP) should be used when a prescription formulation is required.
Military Advisory: U.S. service members should avoid non-FDA-approved peptides, including GHK-Cu. Many hormone-modulating and biologically active compounds appear on the Department of Defense’s prohibited dietary supplement ingredients list and may trigger adverse findings in readiness or medical screenings.
At Sky Health Wellness Clinic, GHK-Cu may be considered as part of an individualized wellness plan only when clinically appropriate and under direct medical supervision. Our approach emphasizes patient education, transparency regarding regulatory status, and evidence-informed guidance when exploring peptide-based options. All decisions regarding GHK-Cu use include assessment of goals, safety considerations, and ongoing monitoring to ensure that any peptide incorporated into care aligns with current medical standards and patient-specific needs.
GLOW Stack Peptides
The GLOW Stack is a conceptual combination of multiple peptides often discussed in wellness settings for their potential roles in cellular repair, skin appearance, inflammation modulation, and tissue support. Each peptide within the stack—such as BPC-157, GHK-Cu, and other research peptides—has been explored in scientific and experimental contexts for different biological pathways related to collagen formation, angiogenesis, antioxidant activity, and tissue signaling. These compounds are not interchangeable and vary significantly in regulatory status, safety data, and approved uses.
At Sky Health Wellness Clinic, peptide-based therapies are only considered when legally permissible, medically appropriate, and aligned with established safety standards. Use of any peptide follows individualized evaluation, patient education, and transparent guidance to help patients understand what is clinically supported, what is investigational, and what is not permitted for human use.
Key Educational Insights About the GLOW Stack:
-
Tissue and Skin Biology Research: Some peptides, such as GHK-Cu, have been studied for roles in collagen production and wound environments in laboratory settings. Research explores how these pathways contribute to skin firmness, elasticity, and cellular remodeling.
-
Inflammation and Regeneration Pathways: Certain peptides have been investigated for their effects on angiogenesis, oxidative stress signaling, and inflammatory balance. These mechanisms are relevant to tissue recovery, aging research, and cellular resilience, although clinical applications vary widely.
-
Hair and Scalp Biology: Peptides such as GHK-Cu have been evaluated in research for their potential effects on follicle signaling and scalp environments. These findings remain early-stage and are not FDA-approved for hair growth treatments.
-
Synergistic Concepts in Multi-Peptide Protocols: Discussions around multi-peptide “stacks” often involve theoretical synergy—how different pathways may complement each other biologically. These combinations are not FDA-approved and are not recognized as medical treatments.
Who Might Explore Educational Information About Multi-Peptide Stacks:
-
Individuals researching cosmetic or dermatologic science related to collagen, recovery, or skin aging.
-
Patients recovering from procedures who are curious about emerging research on tissue environments and healing pathways.
-
People learning about hair and scalp biology and exploring non-medical, research-based mechanisms.
-
Anyone reviewing early-stage or experimental peptide literature under the guidance of qualified clinicians.
Who Might Explore Educational Information About Multi-Peptide Stacks:
Not FDA-Approved: Multi-peptide “stacks”, including research peptides commonly mentioned in the GLOW Stack, are not FDA-approved for anti-aging, skin rejuvenation, hair growth, cosmetic use, or treatment of any disease.
Restricted and Illegal Peptides: Some peptides frequently included in online “stacks,” such as TB-500, are not legal for human use or sale as therapeutic products in the U.S. and are banned by major regulatory and sports agencies.
Investigational Compounds: Safety, dosing, clinical outcomes, and long-term effects for many stack components have not been established through human trials, and use is considered investigational.
Manufacturing Risks: Peptides sold outside FDA-regulated compounding environments may have issues with purity, sterility, or inaccurate potency.
Military Advisory: U.S. service members should avoid non-FDA-approved peptides. Many research peptides appear on the DoD’s Prohibited Dietary Supplement Ingredients list and may trigger adverse findings during medical or readiness screenings.
At Sky Health Wellness Clinic, only FDA-approved medications and legally permitted compounded peptides may be incorporated into patient care, and never for unapproved indications. Any consideration of peptide-based wellness support requires physician oversight, evaluation of regulatory status, risk assessment, and ongoing monitoring. Our priority is ensuring that patients receive accurate information, understand what is medically validated versus investigational, and make informed decisions based on safety and compliance.
%20Peptide%20Therapy%20Las%20Vegas.webp)
Gonadorelin Peptide
Gonadorelin is a synthetic form of gonadotropin-releasing hormone (GnRH), the peptide naturally produced in the hypothalamus that signals the pituitary gland to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH). These hormones play central roles in reproductive physiology, including testosterone production, ovarian function, and broader endocrine regulation.
In medical contexts, Gonadorelin has approved uses related to diagnostic testing of pituitary function. Outside of that narrow scope, its application for fertility improvement, testosterone support, testicular preservation, or hormone enhancement is considered off-label and requires careful evaluation, informed consent, and clinical oversight. Research continues to explore how GnRH analogs interact with endocrine pathways, but many wellness-related applications remain investigational.
Gonadorelin may be considered only when medically appropriate, lawful, and aligned with a patient’s supervised endocrine care plan.
Key Educational Insights About Gonadorelin:
-
Endocrine Signaling Role: Gonadorelin acts on the pituitary gland to stimulate LH and FSH release, both of which influence reproductive system function. Its biological activity is well-characterized in laboratory and diagnostic settings.
-
Reproductive and Hormonal Context: Gonadorelin has been studied for its effects on conditions involving delayed puberty, gonadal function, or hypothalamic–pituitary signaling. These uses vary in regulatory status and require physician guidance.
-
Clinical Oversight Is Essential: Any use of GnRH analogs should involve monitoring of hormone levels, reproductive symptoms, patient history, and treatment tolerability.
-
Administration Considerations: Gonadorelin is typically delivered by injection in controlled settings. Dosing, frequency, and duration must be individualized based on clinical evaluation.
-
Integration into Broader Care: Gonadorelin may be considered within multidisciplinary endocrine care for patients undergoing evaluation for hormone imbalances, fertility issues, or pituitary concerns.
Our Gonadorelin Peptide Therapy is the Perfect Choice for:
-
Adults undergoing supervised evaluation for reproductive or pituitary hormone concerns.
-
Individuals whose primary providers recommend diagnostic or adjunctive endocrine review.
-
Patients learning about hormonal signaling pathways that influence fertility or testosterone production.
-
Those participating in structured wellness programs that include physician-directed hormone monitoring.
Important Legal and Regulatory Information for Gonadorelin:
-
FDA-Approved Uses: Gonadorelin is FDA-approved only for diagnostic evaluation of pituitary function. It is not approved for testosterone enhancement, fertility improvement, testicular preservation, anti-aging, or wellness-related applications.
-
Off-Label Therapy Status: Any use of Gonadorelin outside its approved diagnostic indications is considered off-label and requires explicit clinical justification, informed consent, and careful monitoring.
-
Not a Standalone Fertility or Testosterone Treatment: Gonadorelin cannot be legally marketed or advertised in the U.S. as a therapy for increasing testosterone, improving sperm quality, preventing testicular atrophy, or treating endocrine disorders.
-
Investigational Considerations: Long-term effects, optimal dosing strategies, and safety outcomes for wellness or performance-related use have not been established through large human trials.
-
Manufacturing and Purity Risks: Gonadorelin obtained outside FDA-regulated pharmacy channels may carry risks of contamination, inaccurate potency, or compromised sterility.
-
Military Advisory: U.S. service members should avoid non-FDA-approved peptide uses. Some hormone-modulating peptides appear on the Department of Defense’s Prohibited Dietary Supplement Ingredients list and may trigger adverse findings during medical or readiness screenings.
At Sky Health Wellness Clinic, Gonadorelin may be incorporated into care only when it aligns with FDA regulations, medical necessity, and established diagnostic or adjunctive endocrine protocols. Our approach prioritizes patient safety, transparent communication about regulatory status, and individualized guidance. All treatment decisions involve a review of medical history, laboratory data when indicated, therapeutic goals, and ongoing monitoring to ensure that any use of Gonadorelin adheres to current medical and compliance standards.
Hexarelin Peptide
Hexarelin is a synthetic growth hormone–releasing peptide (GHRP-6 analogue) that has been examined in research settings for its ability to stimulate pulsatile GH release from the pituitary gland. Scientific interest centers on how Hexarelin may influence growth hormone dynamics, muscle physiology, cardiac tissues, and metabolic signaling pathways. Although laboratory and animal studies suggest possible roles in tissue repair, muscle development, and cardiovascular protection, these findings remain investigational and are not established as clinical benefits in humans.
At Sky Health Wellness Clinic, discussions involving Hexarelin focus on understanding how growth hormone pathways function, how peptides influence endocrine signaling in experimental models, and what current evidence does or does not support. All educational guidance emphasizes safety, regulatory status, and the importance of medically supervised decision-making.
Key Educational Insights About Hexarelin:
-
GH Pulse Stimulation: Hexarelin has been shown in research environments to increase GH and IGF-1 output, but long-term effects, desensitization patterns, and clinical implications remain insufficiently studied.
-
Body Composition and Musculoskeletal Factors: Experimental findings investigate whether GH modulation affects muscle growth, fat metabolism, or physical performance. These outcomes have not been validated for therapeutic use.
-
Cardiovascular Mechanisms: Some preclinical models suggest potential interactions with cardiac tissue and oxidative stress pathways. These findings require significantly more research before any clinical relevance can be established.
-
Recovery and Aging Physiology: Interests include how GH modulation might relate to collagen turnover, bone density, immune regulation, or sleep quality. These relationships remain theoretical and unapproved.
-
Administration Considerations: Hexarelin is typically administered by injection in research contexts. Any medical discussion requires a transparent review of risks, uncertainties, and regulatory limitations.
Who May Explore Information About Hexarelin:
-
Individuals learning about growth hormone pathways and investigational peptide analogues.
-
Adults interested in understanding laboratory research around GH modulation under medical supervision.
-
People evaluating endocrine-related wellness programs involving structured supervision and diagnostic review.
-
Patients discussing fatigue, metabolic concerns, or muscle-related issues who wish to better understand GH physiology.
Important Legal and Regulatory Information:
-
Not FDA-Approved: Hexarelin is not approved for treating GH deficiency, muscle gain, fat loss, cardiovascular conditions, anti-aging, athletic performance, or any disease.
-
Not Legal to Market as Therapy: Hexarelin cannot be legally marketed or sold in the United States as a medical or performance-enhancing therapy.
-
Investigational Compound: Human safety data, optimal dosing, long-term effects, and therapeutic applications have not been validated in controlled clinical trials.
-
Manufacturing Risks: If Hexarelin is not manufactured under FDA pharmaceutical standards, unregulated versions may carry risks of contamination, inaccurate potency, or adulteration.
-
Military Advisory: U.S. service members should avoid non-FDA-approved peptides, including Hexarelin. Growth hormone–modulating compounds frequently appear on the Department of Defense’s prohibited ingredients list and may trigger adverse findings in medical, readiness, or compliance screenings.
At Sky Health Wellness Clinic, Hexarelin is addressed only within a structured, physician-supervised framework and with full transparency regarding its investigational status and regulatory limitations. Our focus is safety, informed consent, and evidence-informed education to support individualized wellness planning.
IGF-1 LR3 Peptide
IGF-1 LR3 is a synthetic long-acting analog of insulin-like growth factor-1. It has been studied in research contexts for its ability to bind IGF-1 receptors, influence cellular growth pathways, and alter protein synthesis dynamics. Scientific interest primarily focuses on how IGF-1 LR3 may affect muscle cell signaling, metabolism, neural tissue physiology, and recovery processes. These findings remain investigational and do not constitute established clinical benefits.
Educational discussions around IGF-1 LR3 emphasize the biological role of IGF-1 in human physiology, the differences between endogenous IGF-1 and synthetic analogs, and the uncertainties surrounding long-term effects, safety, and regulatory status.
Key Educational Insights About IGF-1 LR3:
-
Cellular Anabolism and Growth Pathways: IGF-1 LR3 interacts with IGF-1 receptors involved in protein synthesis, satellite cell activation, and cell proliferation. Research models examine its effects on muscle tissue, but these outcomes have not been validated for therapeutic use.
-
Recovery and Tissue Dynamics: Studies explore potential roles in muscle, tendon, and bone repair by modulating cellular regeneration pathways. Evidence in humans remains limited and unapproved.
-
Metabolic Effects: Some data suggest possible influences on insulin sensitivity and nutrient partitioning. These findings are not clinically established and remain theoretical.
-
Aging and Cellular Health: Research investigates connections between IGF-1 signaling and collagen integrity, bone density, fatigue resistance, and other age-associated physiological changes. These are not recognized clinical indications.
-
Neurological Pathways: Preclinical models evaluate whether IGF-1 analogs may affect neuroplasticity, memory, or oxidative stress responses. Human relevance is unknown.
Who May Explore Information About IGF-1 LR3:
-
Individuals studying muscle physiology, cellular growth pathways, or anabolic signaling.
-
Adults seeking medically supervised guidance regarding fatigue, metabolic changes, or age-related declines in growth factor function.
-
Patients discussing recovery, tissue health, or endocrine considerations with licensed clinicians.
-
Those evaluating wellness programs that include structured assessments and laboratory-guided care.
Important Legal and Regulatory Information:
-
Not FDA-Approved: IGF-1 LR3 is not approved for muscle growth, fat loss, anti-aging, athletic performance, recovery enhancement, or treatment of any disease.
-
Not Legal to Market as Therapy: IGF-1 LR3 cannot be legally marketed, sold, or advertised in the U.S. as a medical, anabolic, or performance-enhancing treatment.
-
Investigational Compound: Its safety profile, dosing, long-term risks, and therapeutic applications have not been verified through human clinical trials.
-
Manufacturing Risks: Unregulated production may expose users to impurities, inaccurate potency, or adulteration due to non-pharmaceutical-grade manufacturing.
-
Military Advisory: U.S. service members should avoid non-FDA-approved peptides, including IGF-1 LR3. Many anabolic and hormone-modulating compounds appear on the Department of Defense’s prohibited ingredients list and may trigger adverse findings in readiness or medical screenings.
At Sky Health Wellness Clinic, IGF-1 LR3 is addressed only as an investigational compound and only within physician-supervised discussions that prioritize safety, regulatory transparency, and evidence-informed education. All guidance is individualized, clinically cautious, and grounded in current scientific limitations.
Kisspeptin Peptide
Kisspeptin is a naturally occurring peptide that plays a central role in regulating the reproductive hormone cascade. It acts on the hypothalamus to stimulate gonadotropin-releasing hormone (GnRH), which in turn influences luteinizing hormone (LH) and follicle-stimulating hormone (FSH) production. Scientific interest in Kisspeptin centers on its involvement in reproductive signaling, puberty initiation, fertility pathways, and broader neuroendocrine mechanisms.
While Kisspeptin is being studied for its potential influence on ovulation, testosterone regulation, and reproductive disorders, these applications remain under investigation and are not FDA-approved.
Key Educational Insights About Kisspeptin:
-
Hormonal Cascade Regulation: Kisspeptin activates GnRH-producing neurons, which initiate downstream hormonal processes involved in reproductive function. This is an essential mechanism in puberty, menstrual cycling, and hormonal homeostasis.
-
Reproductive Physiology Research: Studies explore Kisspeptin’s potential roles in menstrual cycle regularity, spermatogenesis, and hypothalamic signaling. These findings remain experimental, and clinical use outside specific diagnostic contexts is off-label.
-
Endocrine Assessment Support: Kisspeptin-related pathways may be reviewed as part of broader endocrine evaluations that examine menstrual irregularities, low gonadotropin states, or hypothalamic-pituitary-gonadal axis function.
-
Administration in Research Settings: Kisspeptin has been delivered through subcutaneous injections during investigational studies to analyze hormonal responses. These methods are not FDA-approved therapies.
-
Customized Clinical Considerations: Discussions about Kisspeptin may involve personalized endocrine assessments, evaluation of underlying causes of hormonal disruption, and collaboration with reproductive specialists.
Who May Explore Information About Kisspeptin:
-
Individuals with physician-supervised evaluation for hypothalamic reproductive disorders.
-
Adults discussing gonadotropin-related conditions with healthcare providers.
-
Couples receiving reproductive counseling or diagnostic testing.
-
Patients working with endocrinologists to assess irregular cycles, low LH/FSH output, or delayed pubertal development.
Important Legal and Regulatory Information:
-
Not FDA-Approved: Kisspeptin is not approved by the FDA for fertility enhancement, hormone optimization, ovulation induction, testosterone support, or treatment of any reproductive condition.
-
Not Legal to Market as Therapy: It cannot be legally promoted or sold in the U.S. as a medical treatment for fertility, hormonal balance, or endocrine enhancement.
-
Investigational Compound: Human safety, effective dosing, clinical benefits, and long-term impacts have not been established through FDA-recognized clinical trials.
-
Manufacturing Risks: Non-regulated versions may contain inconsistent potency, impurities, or adulterants due to a lack of pharmaceutical oversight.
-
Military Advisory: U.S. service members should avoid non-FDA-approved peptides, including Kisspeptin. Hormone-modulating compounds appear on the Department of Defense’s prohibited dietary ingredient list and may trigger adverse findings in medical, readiness, or compliance screenings.
At Sky Health Wellness Clinic, Kisspeptin is addressed only within physician-supervised, evidence-informed consultations. All recommendations prioritize regulatory transparency, patient safety, and individualized assessment rather than unapproved therapeutic claims.
KPV (Lysine-Proline-Valine) Peptide
KPV is a tripeptide fragment derived from the larger melanocortin hormone alpha-MSH. It has been studied in laboratory and early investigative settings for its potential anti-inflammatory and immunomodulatory effects. Research explores how KPV may influence cytokine regulation, epithelial barrier function, and innate immune pathways, particularly in models involving skin, gastrointestinal lining, and inflammatory signaling.
While there is scientific interest in its potential applications, KPV is not FDA-approved for treating inflammation, gut disorders, skin conditions, autoimmune disease, allergies, or any medical diagnosis. Any use in clinical environments is considered investigational and must be approached with careful oversight.
Key Educational Insights About KPV:
-
Inflammatory Pathway Modulation: Research indicates that KPV may interact with melanocortin receptors and downstream signaling involved in inflammation. These findings remain preclinical or investigational.
-
Barrier and Tissue Studies: KPV has been evaluated in models exploring epithelial repair, skin irritation responses, and gastrointestinal lining integrity. These studies do not establish clinical effectiveness.
-
Immune Response Regulation: Early research examines whether KPV influences cytokine release and innate immune signaling. These effects have not been confirmed as therapeutic outcomes in humans.
-
Modes of Administration in Research: Laboratory and investigational settings have used topical, oral, or subcutaneous forms to study absorption and biological activity. None are FDA-approved therapeutic routes.
-
Individualized Clinical Discussion: Patients may discuss KPV within broader wellness evaluations addressing inflammation patterns, skin irritation, gut function, or immune-related concerns under physician supervision.
Who May Explore Information About KPV:
-
Individuals seeking evaluation for chronic inflammation under medical oversight.
-
Patients discussing gastrointestinal or dermatological irritation with healthcare providers.
-
Adults exploring adjunctive assessments for immune or epithelial function.
-
Those working with clinicians to understand potential investigational tools within a larger functional or integrative care plan.
Important Legal and Regulatory Information:
-
Not FDA-Approved: KPV is not approved by the FDA for inflammation control, gut healing, skin disorders, immune modulation, or treatment of any disease.
-
Not Legal to Market as Therapy: It cannot be legally sold or promoted in the U.S. as a medical treatment for inflammation, immune conditions, allergies, or gastrointestinal issues.
-
Investigational Compound: Safety, dosing, long-term effects, and proven clinical applications have not been established through human trials recognized by the FDA.
-
Manufacturing Risks: Non-regulated compounded versions may contain inaccurate potency, impurities, or contaminants due to a lack of pharmaceutical-grade oversight.
-
Military Advisory: U.S. service members should avoid non-FDA-approved peptides, including KPV.
-
Many immune- or hormone-modulating compounds appear on the Department of Defense’s prohibited dietary ingredient list and may trigger adverse findings in readiness evaluations or medical screenings.
At Sky Health Wellness Clinic, discussions about KPV occur only within physician-supervised evaluations. All guidance follows regulatory standards, emphasizes safety and informed decision-making, and integrates KPV solely as part of evidence-informed, individualized wellness planning rather than as an approved therapy.
%20Peptide%20Therapy%20Las%20Vegas.webp)
MOTS-C Peptide
MOTS-C is a naturally occurring mitochondrial-derived peptide that plays a role in regulating cellular energy, metabolic signaling, and stress responses. Research on MOTS-C has focused on how it influences AMPK pathways, glucose utilization, muscle activity, and age-related metabolic changes. Because mitochondrial function declines with age and chronic metabolic stress, MOTS-C has been studied for its potential role in supporting energy production, exercise capacity, and cellular resilience.
Although MOTS-C has gained attention in wellness and longevity spaces, it is not FDA-approved for improving metabolism, enhancing exercise performance, boosting energy, supporting weight management, or treating any medical condition. Its use in clinical or wellness settings is considered investigational, and it should only be explored under the guidance of a licensed medical professional who evaluates whether it is appropriate for patient-specific wellness goals.
What to Expect from MOTS-C Therapy:
-
Clinical Evaluation: A clinician reviews a patient’s medical history, symptoms, metabolic markers, and laboratory results to determine whether investigational peptide therapy may be appropriate within a supervised care plan.
-
Guided Administration: Dosing schedules are tailored to individual goals and tolerability, with ongoing adjustments based on symptom tracking and clinical feedback.
-
Monitoring and Review: Providers may evaluate changes in energy levels, exercise performance, metabolic patterns, or overall wellness to assess patient response over time.
-
Integrated Wellness Support: Programs may incorporate nutrition, physical activity guidance, mitochondrial health strategies, and lifestyle interventions for a comprehensive approach to metabolic wellbeing.
Who May Be Considered for MOTS-C Therapy:
-
Adults seeking structured, clinician-supervised support for metabolic wellness.
-
Individuals experiencing fatigue, reduced exercise tolerance, or age-related metabolic slowing.
-
Patients addressing insulin resistance or obesity-related metabolic concerns under medical care.
-
Those interested in evidence-informed, peptide-based wellness programs guided by a licensed provider.
Important Legal and Regulatory Information for MOTS-C:
-
Not FDA-Approved: MOTS-C is not approved by the U.S. Food and Drug Administration for metabolic health, insulin sensitivity, weight management, anti-aging, exercise-mimicking benefits, or treatment of any disease.
-
Not Legal to Market as Therapy: MOTS-C cannot be legally marketed, sold, or advertised in the United States as a therapeutic product for metabolic enhancement, performance benefits, or cellular optimization.
-
Investigational Compound: MOTS-C remains an investigational peptide. Safety, dosing, long-term outcomes, and clinical applications have not been validated in FDA-recognized human trials.
-
Manufacturing Risks: Non-regulated sources of MOTS-C may pose risks due to impurities, contamination, inaccurate potency, or sterility issues, since its production is not governed by pharmaceutical-grade manufacturing standards.
-
Military Advisory: U.S. service members should avoid non-FDA-approved peptides, including MOTS-C. Many hormone- and metabolism-modulating compounds appear on the Department of Defense’s prohibited dietary ingredient list and may trigger adverse findings during readiness or medical screenings.
At Sky Health Wellness Clinic, MOTS-C is discussed only within physician-supervised care, with careful consideration of its investigational status and regulatory limitations. All treatment decisions are based on individualized assessments, safety considerations, and evidence-informed clinical judgment to support metabolic health within an appropriate medical framework.
Bremelanotide (PT-141) Peptide
Bremelanotide, commonly referred to as PT-141, is a synthetic peptide that interacts with melanocortin receptors involved in signaling pathways related to sexual arousal and neuroendocrine response. In the United States, Bremelanotide is FDA-approved only in its branded form (Vyleesi®) for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women.
PT-141 in non-branded, compounded, or research-labeled forms is not FDA-approved and should not be considered equivalent to the approved prescription medication. Any use outside the specific FDA-approved indication is considered off-label and requires careful clinician supervision.
At Sky Health Wellness Clinic, PT-141 may be discussed only within the context of medically supervised care. Treatment decisions are based on a full evaluation of individual needs, safety considerations, and regulatory guidelines.
What to Expect from PT-141 Therapy:
-
Clinical Evaluation: A licensed provider reviews health history, symptoms, and eligibility for Bremelanotide within its approved or investigational context.
-
Guided Administration: If prescribed, dosing and timing are supervised and adjusted based on patient tolerance and clinical considerations.
-
Monitoring and Follow-Up: Providers may evaluate response, side effects, or any reported changes to ensure safe use.
-
Educational Support: Patients receive information on lifestyle, relationship factors, and underlying contributors to sexual wellness.
Who May Be Considered for PT-141 Therapy:
-
Adult women who meet diagnostic criteria for HSDD and may be eligible for the FDA-approved form of Bremelanotide.
-
Individuals whose healthcare provider recommends further evaluation of sexual wellness concerns under medical supervision.
-
Adults exploring clinically supervised treatment options for sexual health or intimacy-related concerns.
-
Patients seeking structured therapeutic oversight for peptide-based care program
Important Legal and Regulatory Information:
-
FDA Approval: Only the branded version, Vyleesi®, is FDA-approved — and only for HSDD in premenopausal women.
-
Unapproved Forms: Compounded or research versions of PT-141 are not FDA-approved and may vary in purity, potency, and sterility.
-
Off-Label Use: Any use outside the FDA-approved indication requires physician oversight and informed consent.
-
Quality Assurance: Products from non-FDA-approved facilities or labeled for research-only use may not meet pharmaceutical manufacturing standards.
-
Military Members: U.S. service members should avoid PT-141 and other peptide hormones, as they are on the military's prohibited dietary supplement list.
At Sky Health Wellness Clinic, our goal is to provide safe, transparent, and evidence-based sexual health care. Bremelanotide is prescribed only for approved indications and under ongoing medical supervision to ensure patient safety and satisfaction.
%20Peptide%20Therapy%20Las%20Vegas.webp)
Selank Peptide
Selank is a synthetic analog of tuftsin, a naturally occurring peptide involved in immune and neurological regulation. It has been studied for its potential effects on anxiety reduction, neurotransmitter balance, cognitive performance, and stress resilience. Research has explored Selank’s influence on GABA and serotonin modulation, BDNF expression, and its role in supporting stable mood and adaptive emotional responses.
Although Selank is sometimes discussed in wellness settings for stress management or cognitive support, it is not FDA-approved for the treatment of anxiety disorders, depression, ADHD, PTSD, cognitive decline, or any neurological or psychiatric condition. Any use outside research contexts is considered investigational and should be evaluated carefully by a licensed clinician.
What to Expect from Selank Therapy:
-
Clinical Review: Providers assess medical history, neurological symptoms, mental health concerns, and relevant lab or diagnostic information to help determine whether investigational peptide use may be appropriate within a supervised care plan.
-
Guided Dosing: Nasal spray or subcutaneous dosing schedules are customized to patient tolerance, symptom patterns, and clinical objectives, with modifications made during follow-up assessments.
-
Monitoring and Adjustments: Clinicians may review changes in mood stability, stress resilience, cognitive function, or behavioral patterns to evaluate response over time.
-
Integrated Care Approach: Patients may receive additional guidance related to sleep, nutrition, stress-modulation techniques, and lifestyle interventions that support broader neurological wellness.
Who May Be Considered for Selank Therapy:
-
Adults seeking clinician-supervised support for stress, mood variability, or overwhelm.
-
Individuals experiencing cognitive difficulties such as reduced focus, mental fatigue, or memory concerns.
-
Patients working with behavioral-health or neurology providers on adjunctive, non-sedating options for emotional regulation.
-
Adults interested in structured wellness programs addressing resilience, cognitive function, or nervous-system balance.
Important Legal and Regulatory Information for Selank:
-
Not FDA-Approved: Selank is not approved by the U.S. Food and Drug Administration for anxiety reduction, ADHD, cognitive enhancement, PTSD support, mood regulation, or treatment of any psychiatric or neurological disorder.
-
Not Legal to Market as Therapy: Selank cannot be legally marketed or advertised in the United States as a medical treatment for anxiety, depression, cognitive decline, or emotional-health improvement.
-
Investigational Compound: Selank remains an investigational peptide. Human safety data, clinical dosing standards, and long-term effects have not been established through FDA-recognized trials.
-
Manufacturing Risks: Non-regulated sources may pose risks due to impurities, contamination, incorrect strength, or sterility failures, since Selank is not produced under FDA pharmaceutical standards.
-
Military Advisory: U.S. service members should avoid non-FDA-approved peptides, including Selank.
Many compounds affecting neurological or hormonal pathways appear on the Department of Defense’s prohibited dietary ingredient list and may lead to adverse findings in readiness or medical screenings.
Selank may be reviewed only within physician-supervised care, and all decisions rely on a patient’s health history, symptom profile, and regulatory considerations. At Sky Health Wellness Clinic, Selank is incorporated solely in accordance with its investigational status, prioritizing safety, transparency, and evidence-informed clinical judgment within structured wellness programs.
Semaglutide Peptide
Semaglutide is a GLP-1 receptor agonist that has been extensively studied for its effects on glucose regulation and metabolic pathways. It works by mimicking the action of the body’s natural incretin hormones, which influence insulin secretion, slow gastric emptying, and affect appetite signaling. In clinical practice, Semaglutide is used in its FDA-approved forms (Ozempic®, Wegovy®, and Rybelsus®) for specific indications related to type 2 diabetes and chronic weight management under appropriate medical supervision.
At Sky Health Wellness Clinic, Semaglutide may be incorporated into a patient’s care plan when clinically appropriate and prescribed by a licensed provider. All dosing, monitoring, and adjustments are carried out through structured medical oversight to support safety and individualized decision-making.
What to Expect from Semaglutide Therapy:
-
Medical Evaluation: A licensed provider reviews medical history, current medications, and eligibility for FDA-approved Semaglutide formulations.
-
Supervised Dosing: Treatment follows a gradual titration schedule to assess tolerance and minimize common gastrointestinal side effects.
-
Ongoing Monitoring: Follow-up visits may include reviewing symptoms, metabolic markers, and overall treatment response to guide any necessary adjustments.
-
Integrated Support: Patients may receive guidance related to nutrition, routine physical activity, and lifestyle habits that complement metabolic health goals.
Who May Be Considered for Semaglutide Therapy:
-
Adults with type 2 diabetes seeking improved glycemic control through an FDA-approved GLP-1 medication.
-
Individuals with obesity or overweight who meet eligibility criteria for chronic weight management with Semaglutide under medical supervision.
-
Patients referred by their primary care provider for structured metabolic health support.
-
Adults who benefit from clinician-supervised medication management as part of a broader wellness plan.
Important Legal and Regulatory Information for Semaglutide:
-
FDA-Approved Status: Semaglutide is FDA-approved only for specific formulations and indications (type 2 diabetes and chronic weight management). It cannot be marketed for non-approved uses.
-
No Compounded Substitutes: The FDA has stated that compounded Semaglutide is not the same as approved products. Some compounded versions may use salt forms or ingredients not permitted for compounding, creating safety and regulatory concerns.
-
Off-Label Use Requires Oversight: Any use of Semaglutide outside its approved indications is considered off-label and must follow individualized clinical judgment by a licensed provider.
-
Manufacturing and Quality Risks: Non-approved or non-regulated versions may contain inaccurate strengths, impurities, or unverified ingredients that pose safety risks.
-
Military Advisory: U.S. service members should avoid non-FDA-approved Semaglutide products. Ingredients found in unauthorized or compounded peptides may appear on the Department of Defense’s prohibited substances list and can result in adverse findings during readiness or medical screenings.
If you'd like to learn more, visit our learning center's Ultimate Guide to Semaglutide.
At Sky Health Wellness Clinic, Semaglutide is used only for its FDA-approved indications and within the scope of professional medical supervision. The goal is to provide clear, evidence-informed guidance so patients can make well-supported decisions about their metabolic health.
Semax Peptide
Semax is a synthetic nootropic peptide originally developed in Russia and studied for its potential effects on neuroprotection, cognitive support, and modulation of neurotransmitter pathways. Research has explored its ability to influence brain-derived neurotrophic factor (BDNF), memory formation, learning efficiency, and stress adaptation. However, Semax is not FDA-approved for treating any medical or psychiatric condition in the United States.
In wellness settings, Semax may be considered only when a licensed clinician determines that a peptide-based cognitive support plan is appropriate, with clear oversight of dosing, safety considerations, and individual response.
What to Expect from Semax Therapy:
-
Clinical Evaluation: A provider reviews medical history, neurological concerns, medications, and overall suitability before determining whether Semax is appropriate in a wellness-oriented plan.
-
Guided Administration: Semax may be administered as a nasal spray or subcutaneous injection. Dosing schedules are tailored to tolerance and individual cognitive or wellness goals.
-
Monitoring and Follow-Up: Visits may include discussion of concentration, stress resilience, memory, mood, and sleep to evaluate response and adjust the regimen if needed.
-
Integrated Support: Patients may receive guidance related to sleep hygiene, stress regulation, nutrition, or brain-supportive practices that complement cognitive wellness
Who May Be Considered for Semax Therapy:
-
Adults pursuing clinician-supervised cognitive wellness strategies.
-
Individuals seeking support for focus, mental clarity, or stress resilience within a structured wellness program.
-
Patients collaborating with functional medicine or integrative providers for non-pharmaceutical cognitive support.
-
Adults exploring adjunctive approaches to optimize learning efficiency or mental performance with clinical guidance.
Important Legal and Regulatory Information for Semax:
-
Not FDA-Approved: Semax is not approved by the U.S. Food and Drug Administration for any medical, psychiatric, or cognitive indication.
-
Not Legal to Market as Therapy: Semax cannot be sold or advertised as a treatment for anxiety, ADHD, depression, cognitive decline, stroke, or any other disease-related purpose in the United States.
-
Investigational Compound: Human safety data, long-term effects, and standardized clinical applications have not been established through U.S.-regulated trials. Its use is considered investigational and requires clinician oversight.
-
Manufacturing Risks: Non-regulated vendors may contain impurities, inaccurate concentrations, or non-pharmaceutical ingredients that increase safety risks.
-
Military Advisory: U.S. service members should avoid non-FDA-approved peptides, including Semax. Many compounds that modulate neurological or hormonal pathways appear on the Department of Defense’s prohibited ingredients list and may trigger adverse findings during readiness or medical screenings.
At Sky Health Wellness Clinic, Semax is used only under appropriate clinical supervision and with transparent communication regarding its regulatory status. Treatment decisions prioritize safety, patient education, and evidence-informed guidance as part of individualized wellness planning.
Sermorelin Peptide
Sermorelin is a synthetic analog of growth hormone–releasing hormone (GHRH). It works by stimulating the pituitary gland to produce endogenous growth hormone, a natural hormone involved in metabolism, cellular repair, and developmental processes. Sermorelin has been studied for its role in evaluating pituitary function and for its potential to influence growth hormone dynamics in adults under certain clinical circumstances.
Although Sermorelin is sometimes used in wellness-oriented care plans, it is not FDA-approved for anti-aging, athletic performance, or body composition enhancement. Any use outside of its recognized diagnostic context is considered off-label and must be approached with careful clinical supervision.
At Sky Health Wellness Clinic, Sermorelin may be included in patient care only when a licensed provider determines it is appropriate and safe. All treatment decisions involve individualized assessment, laboratory review when indicated, and ongoing monitoring.
What to Expect from Sermorelin Therapy:
-
Clinical Evaluation: A provider reviews medical history, symptoms, and laboratory results to determine whether Sermorelin is appropriate for inclusion in a patient’s care plan.
-
Guided Administration: Dosing schedules are developed based on patient tolerance and clinical objectives, with adjustments made during follow-up visits.
-
Ongoing Monitoring: Providers may review changes in symptoms, sleep patterns, or general wellness to evaluate how a patient is responding.
-
Integrated Care: Patients may receive additional guidance regarding nutrition, activity, and lifestyle practices to support overall wellness.
Who May Be Considered for Sermorelin Therapy:
-
Adults with clinically identified growth hormone concerns evaluated under medical supervision.
-
Individuals seeking physician-directed support for wellness programs that incorporate hormone-modulating therapies.
-
Patients referred by their primary provider for diagnostic or adjunctive endocrine-related evaluation.
-
Adults who benefit from structured, clinician-managed treatment plans involving peptide-based therapies.
Important Legal and Regulatory Information:
-
Not FDA-Approved for Anti-Aging or Performance Use: Sermorelin is approved by the FDA only for the diagnostic evaluation of growth hormone secretion in children. It is not approved for anti-aging, athletic performance, body composition enhancement, or general wellness purposes.
-
Not Legal to Market as Therapy for Unapproved Uses: Sermorelin cannot be legally marketed, sold, or advertised in the U.S. as a treatment for aging, muscle growth, fat loss, vitality enhancement, or any non-approved indication. Its use in wellness settings is off-label and must be clinically justified by a licensed prescriber.
-
Investigational Compound in Adults: Safety, long-term effects, and efficacy of Sermorelin for adult wellness objectives have not been established through FDA-regulated human trials. Any use outside its approved scope should be approached with careful medical oversight.
-
Manufacturing and Quality Considerations: Potency, purity, and sterility may vary depending on the compounding pharmacy. Only pharmacies registered with the FDA and compliant with current good manufacturing practices (cGMP) should be used.
-
Military Advisory: U.S. service members should avoid non-FDA-approved peptide hormones, including Sermorelin. Many hormone-modulating compounds appear on the Department of Defense’s prohibited dietary supplement ingredients list and may trigger adverse findings in readiness or medical screenings.
If you'd like to learn more, visit our learning center's Ultimate Guide to Sermorelin.
At Sky Health Wellness Clinic, Sermorelin is used only under appropriate clinical supervision and with full transparency regarding its regulatory status. Our approach prioritizes safety, patient education, and evidence-informed guidance when incorporating peptide-based therapies into individualized wellness programs.
TB-500 Peptide
TB-500 is a synthetic peptide fragment modeled after a portion of Thymosin Beta-4, a naturally occurring protein involved in cellular movement and structural organization. TB-500 has been studied in laboratory and animal settings for its effects on actin regulation and tissue dynamics. TB-500 has no FDA approval for any medical use and has not been evaluated for safety or effectiveness in humans.
TB-500 is not approved for human use in the United States, Canada, or many other countries. It is also prohibited by major athletic regulatory bodies, including the World Anti-Doping Agency (WADA). Products marketed online as TB-500 are typically labeled for research purposes only, and their manufacturing quality, purity, and safety cannot be assured. Because it has not undergone human clinical trials, potential risks, side effects, interactions, and long-term outcomes remain unknown.
Sky Health Wellness Clinic does not promote, sell, or administer TB-500 as a therapeutic product. The information provided here is for educational purposes to help patients understand the regulatory and scientific context surrounding this peptide.
What to Know About TB-500:
-
Regulatory Status: TB-500 is not FDA-approved and cannot be prescribed or administered for therapeutic use in the United States.
-
Human Use: There is no established safety profile due to the absence of human clinical trials.
-
Quality Concerns: Products sold online may vary significantly in purity, potency, and formulation.
-
Sports Restrictions: TB-500 is banned by WADA and other athletic organizations.
-
Research Context: Existing studies are limited to preclinical environments and involve laboratory or animal models.
Who Should Avoid TB-500:
Because TB-500 is not approved for human use, individuals should avoid using it for any therapeutic purpose, wellness program, injury recovery, or performance enhancement. This includes:
-
Athletes subject to anti-doping regulations
-
Individuals seeking unregulated performance or recovery products
-
Anyone considering peptides sourced from non-verified online vendors
-
Patients with medical conditions that require supervised, evidence-based treatment
Important Legal and Regulatory Information for TB-500:
-
Not FDA-Approved: TB-500 is not approved to diagnose, treat, cure, or prevent any disease and is not authorized for medical or performance-related use in humans.
-
Not Legal to Market as Therapy: It cannot be legally sold or advertised in the United States as a medical or performance-enhancing treatment.
-
Investigational Compound: Human dosing, safety, long-term effects, clinical applications, and therapeutic outcomes have not been established through regulated trials.
-
Manufacturing Risks: Non-regulated manufacturing significantly increases the likelihood of impurities, bacterial contamination, inaccurate potency, or adulterants.
-
Military Advisory: U.S. service members should avoid non-FDA-approved peptides, including TB-500. Many hormone-modulating and research-grade compounds appear on the Department of Defense’s prohibited dietary supplement ingredients list and may trigger adverse findings during readiness or medical screenings.
Sky Health Wellness Clinic encourages patients to rely on approved, clinically validated therapies and to seek guidance from licensed medical professionals regarding safe and appropriate options for their health goals. We remain committed to providing accurate, evidence-informed education so individuals can make well-supported decisions within a regulated medical environment.
Tesamorelin Peptide
Tesamorelin is a synthetic peptide analog of growth hormone–releasing hormone (GHRH). It has been studied for its ability to stimulate endogenous growth hormone production, which plays a role in metabolism, cellular repair, and various endocrine functions. Tesamorelin is FDA-approved only for the reduction of excess abdominal fat in adults with HIV-associated lipodystrophy and is not approved for general weight loss, anti-aging purposes, or athletic enhancement.
In clinical settings, Tesamorelin may be prescribed when a licensed medical provider determines that a patient meets eligibility criteria for its approved indication. Any use outside of its FDA-approved purpose is considered off-label and requires careful medical oversight.
What to Expect from Tesamorelin Therapy:
-
Medical Evaluation: A provider reviews medical history, current metabolic health, and any relevant laboratory findings to determine if Tesamorelin is appropriate within its approved context.
-
Dose Guidance: Treatment typically involves scheduled subcutaneous administration following a standardized protocol, with clinician-directed adjustments as needed.
-
Monitoring and Follow-Up: Providers may track patient response, review metabolic markers when appropriate, and assess overall tolerance during follow-up visits.
-
Supportive Lifestyle Review: Patients may receive general guidance on nutrition and activity patterns that complement metabolic wellness under clinical supervision.
Who May Be Considered for Tesamorelin Therapy:
-
Adults diagnosed with HIV-associated lipodystrophy who meet clinical criteria for the medication’s FDA-approved use.
-
Patients referred by a licensed healthcare provider for evaluation related to changes in body fat distribution within Tesamorelin’s studied context.
-
Individuals participating in medically supervised endocrine or metabolic care programs.
-
Adults requiring structured oversight for peptide-based therapies as part of a physician-guided health plan.
Who May Be Considered for Tesamorelin Therapy:
-
FDA-Approved for a Single Indication: Tesamorelin is approved exclusively for the treatment of excess abdominal fat in adults with HIV-associated lipodystrophy. It is not authorized for weight loss, anti-aging, or performance enhancement.
-
Off-Label Restrictions: Use outside the FDA-approved purpose requires clinician oversight, carries additional risk, and has not been validated through large-scale human trials.
-
Investigational Limitations: Long-term safety, metabolic outcomes, and broader clinical applications beyond the approved indication have not been established.
-
Manufacturing and Sourcing Considerations: Only pharmacy-dispensed formulations produced under regulated conditions should be used. Non-regulated online products increase the risk of impurities or inaccurate potency.
-
Military Advisory: U.S. service members should avoid non-FDA-approved peptides, including hormone-modulating compounds. Many appear on the Department of Defense’s prohibited dietary supplement list and may trigger adverse findings during readiness or medical screenings.
At Sky Health Wellness Clinic, Tesamorelin is prescribed only for its FDA-approved indication and used within a framework of transparent, evidence-informed, and medically supervised care. Our focus is to help patients understand the scientific and regulatory background of peptide therapies so they can make informed decisions with their healthcare provider.
Schedule a consultation to discuss your endocrine profile and determine whether Tesamorelin may be appropriate for your individual care plan.
Thymosin Alpha 1 (Tα1) Peptide
Thymosin Alpha-1 (Tα1) is a synthetic peptide modeled after a naturally occurring thymic protein involved in immune system signaling. It has been studied internationally for its potential role in supporting immune modulation, T-cell activity, and related cellular processes. Outside the United States, Tα1 is approved in certain countries for specific medical indications; however, its regulatory status varies widely.
In the United States, Thymosin Alpha-1 is not FDA-approved for any therapeutic use and cannot be marketed as a treatment for infections, immune disorders, chronic illness, cancer support, or vaccine enhancement. Any use in a wellness or medical context is considered off-label and investigational, requiring careful clinical judgment and physician oversight. Additionally, commercial products labeled as Tα1 may differ in purity, quality, and manufacturing standards.
What to Expect from Thymosin Alpha-1 (Tα1) Therapy:
-
Clinical Review: A licensed provider evaluates medical history and immune-related concerns to determine whether a peptide-based approach is appropriate within an investigational framework.
-
Supervised Administration: If Tα1 is considered for off-label use, dosing plans are developed and monitored under professional supervision to assess tolerance and safety.
-
Ongoing Monitoring: Providers may review lab data, immune markers, or patient-reported symptoms over time to ensure responsible and safe oversight.
-
Supportive Education: Patients may receive general guidance on immune-supportive lifestyle practices such as sleep, nutrition, and stress management.
Who May Be Considered for Thymosin Alpha-1 (Tα1) Therapy:
-
Adults whose healthcare provider recommends further evaluation of immune-related concerns within a supervised program.
-
Individuals participating in physician-directed wellness plans that include immune-modulating peptides on an investigational basis.
-
Patients who have been referred for consideration of peptide-based supportive care within regulatory limits.
-
Adults seeking structured medical oversight when exploring peptide therapies with variable international regulatory status.
Important Regulatory and Legal Information:
-
Not FDA-Approved: Thymosin Alpha-1 is not approved by the U.S. Food and Drug Administration for any medical indication.
-
Legality: Because it is not FDA-approved, Tα1 cannot be sold or marketed as a therapeutic product in the United States. It may only be used in limited, clinician-supervised contexts where off-label investigational use is permitted.
-
International Use: Tα1 is approved in some countries for specific conditions, but these approvals do not apply within the U.S.
-
Quality Concerns: Products sold online as Thymosin Alpha-1 may not meet pharmaceutical standards for purity, sterility, or potency.
-
Clinical Transparency: Patients should be fully informed about regulatory status, investigational nature, and the lack of FDA evaluation for safety or efficacy.
-
Military members: U.S. service members should avoid Tα1 and other peptide hormones, as they are on the military's prohibited dietary supplement list.
At Sky Health Wellness Clinic, our role is to provide clear, evidence-informed education and ensure that any peptide considered for use is handled with full transparency, safety oversight, and respect for federal and state regulatory guidelines.
%20Peptide%20Therapy%20Las%20Vegas.webp)
Tirzepatide Peptide
Tirzepatide is a dual GIP/GLP-1 receptor agonist studied for its effects on glucose regulation and metabolic function. It works by interacting with incretin pathways involved in insulin secretion, appetite signaling, and gastrointestinal transit. The medication is FDA-approved (Mounjaro®) for improving glycemic control in adults with type 2 diabetes and may also be prescribed for chronic weight management under FDA review and specific eligibility criteria.
At Sky Health Wellness Clinic, Tirzepatide may be considered as part of a medically supervised program when a licensed provider determines that an FDA-approved formulation is appropriate. Treatment is monitored through structured follow-up visits to ensure safe titration and individualized care.
What to Expect from Tirzepatide Therapy:
-
Medical Assessment: A clinician evaluates health history, diabetes status, BMI criteria, and overall suitability for Tirzepatide.
-
Guided Dose Adjustment: Treatment typically involves gradual dose escalation to assess tolerance and minimize gastrointestinal side effects.
-
Regular Monitoring: Follow-ups may include reviewing blood glucose trends, treatment response, and potential side effects to guide safe use.
-
Supportive Counseling: Patients receive guidance on nutrition, physical activity, and lifestyle practices that complement metabolic health goals under medical supervision.
Who May Be Considered for Tirzepatide Therapy:
-
Adults with type 2 diabetes who may benefit from an FDA-approved dual incretin medication for glycemic control.
-
Individuals with obesity or overweight who meet clinical criteria for consideration of weight-management therapy under medical direction.
-
Patients referred by their healthcare provider for medication-based metabolic support.
-
Adults seeking structured, clinician-supervised care related to metabolic wellness.
Important Legal and Regulatory Information for Tirzepatide:
-
FDA-Approved for Specific Indications: Tirzepatide is FDA-approved for improving glycemic control in adults with type 2 diabetes (Mounjaro®). It is not approved for cosmetic weight loss, anti-aging, or performance enhancement purposes.
-
Weight-Management Use Requires Eligibility: Prescribing Tirzepatide for chronic weight management is limited to FDA-approved formulations and only when strict clinical criteria are met. Any use outside approved pathways requires clinician oversight.
-
Off-Label Restrictions: Use beyond the FDA-approved indication carries additional risk, requires medical supervision, and lacks long-term safety validation outside approved contexts.
-
Investigational Limitations: Long-term metabolic, endocrine, or cardiovascular outcomes for non-diabetic or non-qualified populations have not been established in large-scale trials.
-
Manufacturing and Sourcing Risks: Non-regulated online products marketed as Tirzepatide may contain incorrect potency, impurities, or harmful additives. Only pharmacy-dispensed, FDA-regulated formulations should be used.
-
Military Advisory: U.S. service members should avoid non-FDA-approved peptide or hormone-modulating compounds. Many appear on the Department of Defense prohibited ingredients list and may trigger adverse findings in readiness or medical screenings.
If you'd like to learn more, visit our learning center's Ultimate Guide to Tirzepatide.
At Sky Health Wellness Clinic, Tirzepatide is prescribed only for FDA-approved uses and within the scope of appropriate clinical supervision. Our role is to provide clear, evidence-informed guidance to support patient understanding and safe participation in metabolic health programs.
Wolverine Stack Peptides
The Wolverine Stack combines two investigational peptides, BPC-157 and TB-500, which are frequently studied for their potential roles in tissue regeneration, inflammation modulation, and recovery support. These compounds are of interest in research settings due to their interactions with cellular repair pathways, angiogenesis, and musculoskeletal healing processes.
It is important to note that neither BPC-157 nor TB-500 is FDA-approved for human use. Both are considered research peptides, and their effects, safety profiles, and clinical applications remain under investigation. Any inclusion of these agents in care plans requires careful evaluation, informed consent, and physician oversight.
At Sky Health Wellness Clinic, educational discussions around this stack focus on helping patients understand biological pathways involved in tissue recovery, inflammation, and cellular healing.
Key Educational Insights About the Wolverine Stack:
-
Tissue Repair Pathways: BPC-157 and TB-500 have been studied for their interactions with processes related to tendon, ligament, and muscle repair, including angiogenesis and cellular migration. These potential mechanisms remain experimental and require further research.
-
Inflammation and Oxidative Stress: Both compounds have been evaluated in preclinical studies for their potential to influence inflammatory signaling. Their relevance in human therapeutic contexts is not established.
-
Mobility and Musculoskeletal Function: Research interest includes how these peptides may relate to joint integrity, connective tissue recovery, and post-injury function. These findings are preliminary and not validated for clinical treatment.
-
Systemic and Cardiovascular Context: Some exploratory studies examine ancillary effects on circulation, tissue perfusion, and repair processes, though none are approved indications.
-
Delivery Considerations: Research compounds are commonly administered by injection in laboratory settings. Any clinical discussion must include risks, uncertainties, and regulatory considerations.
Who May Explore Information About Wolverine Stack Concepts:
-
Individuals learning about investigational peptide combinations and their proposed mechanisms.
-
Patients recovering from injuries who wish to understand biological repair pathways.
-
People evaluating options for comprehensive regenerative or musculoskeletal wellness programs under clinical supervision.
-
Individuals interested in adjunctive recovery support while acknowledging the experimental status of these peptides.
Who May Explore Information About Wolverine Stack Concepts:
-
Not FDA-Approved: BPC-157 and TB-500 are not approved for treating injuries, inflammation, tissue repair, performance enhancement, or any medical condition.
-
Not Legal to Market as Therapy: These peptides cannot be legally marketed or sold in the U.S. as medical treatments, wellness therapies, or performance-enhancing products.
-
Investigational Compounds: Human safety, dosing, long-term effects, and clinical applications have not been established through controlled human trials.
-
Manufacturing Risks: If these substances are not produced under FDA-regulated pharmaceutical standards, non-regulated manufacturing may increase risks of contamination, incorrect dosing, impurities, or inaccurate potency.
-
Military Advisory: U.S. service members should avoid non-FDA-approved peptides, including BPC-157 and TB-500. Many hormone-modulating or investigational compounds appear on the Department of Defense’s prohibited ingredients list and may trigger adverse findings in readiness, medical, or compliance screenings.
If you'd like to learn more, visit our learning center's Ultimate Guide to BPC-157, which provides an indepth look into the main ingredient of The Wolverine Stack.
At Sky Health Wellness Clinic, BPC-157 and TB-500 are discussed only within the context of research-based information and when appropriate for physician-supervised wellness evaluations. Their use is approached with full acknowledgment of regulatory limitations, investigational status, and unknown long-term outcomes. Our priority is patient safety, transparency, and informed decision-making regarding any peptide-related discussion or plan.
Legal Notice & Patient Responsibility
This page, including all descriptions of peptide therapies, is provided for informational purposes only and does not constitute medical advice. Peptide treatments should only be administered under the supervision of a qualified, licensed healthcare provider. Individual responses to therapy may vary, and outcomes cannot be guaranteed. All patients are required to review and sign a liability waiver before treatment can begin. Visit our full medical disclaimer for more information.
Risks and Side Effects
All medical procedures involve risks. Possible side effects of peptide therapy may include injection site reactions, allergic responses, or interactions with other medications or health conditions. You should consult your primary care provider before proceeding with any treatment.
Medical Supervision & Eligibility
Our clinic provides peptide therapy only when prescribed by a licensed provider. Some peptides may not be FDA-approved for all uses, and using them for unapproved purposes may carry regulatory or legal risk.
No Guarantee of Results
While peptide therapy may support wellness objectives, no specific outcomes can be assured.
Liability Release
By participating in peptide therapy at Sky Health Wellness Clinic, you accept responsibility for the treatment and agree to release and indemnify the clinic, its providers, and related parties from liability for any adverse events—except where caused by proven gross negligence or willful misconduct.
Governing Law
These terms are governed by the laws of Nevada. Any disputes will be resolved via binding arbitration in Clark County, Nevada. You waive the right to a jury trial in all related matters.
Warning for Military Personnel
Military members: U.S. service members should avoid peptide hormones and other non-FDA-approved peptide products. Many peptides appear on the Department of Defense’s prohibited dietary supplement list and may lead to disqualification, disciplinary action, or adverse findings during medical or readiness screenings.